Navigation Links
Innocoll Appoints Anthony H. Wild Ph.D. to Its Board of Directors
Date:7/21/2008

t, Innocoll's Chairman of the board.

"I am excited with the Innocoll products and am impressed with the thorough and well-thought out development plans in place. I look forward to working with the board and management to move the Innocoll portfolio forward to commercialization," said Dr. Wild.

About Innocoll, Inc.

Innocoll is a privately held, biopharmaceutical company focused on biodegradable surgical implants and topically applied healthcare products. It develops and manufactures a range of pharmaceutical products and medical devices using its proprietary collagen-based technologies, CollaRx(R) and Liquicoll(R). Innocoll 's lead product, Gentamicin Surgical Implant for the treatment and prevention of surgical site infections, is approved for sale in 49 countries in Europe, Latin America, Middle East, Africa and Asia and is marketed under the following trade names; COLLATAMP(R) G, COLLATAMP(R) EG, SULMYCIN(R) IMPLANT, GARAMYCIN(R) SCHWAMM, DURACOL(R), DURACOLL(R), GENTACOL(R), GENTACOLL(R), GARACOL(R), GARACOLL(R), and CRONOCOL(R). In 2005, Innocoll acquired the worldwide marketing rights for this product from Essex Chemis AG, an affiliated company of Schering-Plough Corporation (NYSE: SGP) and in August 2007 sold its marketing rights, with the exception of the US, to EUSA Pharma. Gentamicin Surgical Implant is currently in phase 3 development in the US for the prevention of surgical site infections. Other late stage pharmaceutical products in Innocoll's development pipeline include CollaRx Gentamicin Topical for the treatment and prevention of infected diabetic foot ulcers and CollaRx Bupivacaine Implant for the management of post-operative pain, both of which are currently in Phase 2 development. For more information, plea
'/>"/>

SOURCE Innocoll Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Innocoll Announces Dosing of First Patient in a Second US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
2. Innocoll Announces Closing of $30 Million Equity Financing Investment
3. AMT Appoints Director Global Marketing and Sales
4. Yongye Biotechnology International, Inc. Appoints New Independent Auditor
5. WuXi PharmaTech (NYSE: WX) Appoints Dr. Debra Yu as VP of Strategy
6. PharmAthene Appoints Jordan P. Karp, J.D. Senior Vice President and General Counsel
7. Bioheart, Inc., Board Appoints Howard J. Leonhardt Chief Executive Officer
8. Transcept Pharmaceuticals Appoints Key Senior Executives
9. WuXi PharmaTech (NYSE: WX) Appoints Mr. Bob Zhu as VP of HR
10. Exiqon Appoints Cynthia French as Chief Scientific Officer and Erik Holmlin as Chief Commercial Officer
11. Stason Pharmaceuticals, Inc. Appoints Diana Wood as Vice President, Business Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... ... September 01, 2015 , ... ... today that the National Institutes of Health (NIH) has awarded the company a ... by the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases. AxioMx ...
(Date:9/1/2015)... NJ (PRWEB) , ... September 01, 2015 , ... ... that highlights the opportunities for advanced analytics utilizing data lakes in the healthcare ... industries, Healthcare has seen an explosion of data over the last few years as ...
(Date:9/1/2015)... ... September 01, 2015 , ... Research ... California Los Angeles, Boston University School of Medicine, Frederick National Laboratory for Cancer ... the world’s first multidisciplinary Open Access journal. , Christopher Ryan PhD, of ...
(Date:8/31/2015)... GUELPH, ON , Aug. 31, 2015 /PRNewswire/ - BIOREM ... new orders totalling $5.7 million. The orders are for air emission ... "Of particular note is a large order for a ... our equipment will be replacing a competitor,s system that failed ... see in our engineered solutions," said Derek S. Webb ...
Breaking Biology Technology:AxioMx Announces Receipt of SBIR Grant for DNA-Protein Complex Antigen Development 2AxioMx Announces Receipt of SBIR Grant for DNA-Protein Complex Antigen Development 3New White Paper Explores Data Lake Opportunities in the Healthcare Industry 2Synedgen’s Director for Pharmaceutical Manufacturing Publishes New Research 2Synedgen’s Director for Pharmaceutical Manufacturing Publishes New Research 3
... 2012   Spherix Incorporated (NASDAQ: SPEX ... diabetes, metabolic syndrome and atherosclerosis, and provider of technical ... pharmaceutical companies, today announced that it has entered into ... its common stock and warrants to purchase shares of ...
... Cambrex Corporation (NYSE: CBM ) announced ... on Monday, February 6, 2012 after the market closes. ... call to discuss the fourth quarter 2011 financial results.  ... Tuesday, February 7, 2012 at 8:30 a.m. Eastern Time ...
... strength of spider silk, the robust nature of the ... tears and winds that exceed hurricane strength. Now, ... with complex computer simulations has shown that web durability ... the overall web design compensates for damage and the ...
Cached Biology Technology:Spherix Announces Registered Direct Offering of $1.15 Million 2Spherix Announces Registered Direct Offering of $1.15 Million 3A spider web's strength lies in more than its silk 2A spider web's strength lies in more than its silk 3A spider web's strength lies in more than its silk 4
(Date:8/20/2015)... , Aug. 20, 2015 The ... consumers that are active and healthy. However, wearable ... the hospital environment to help improve diagnostic capabilities ... video from the Wearable Technologies Conference 2015 ... new applications for wearables in healthcare.    ...
(Date:8/18/2015)... , Aug. 17, 2015 Research ... addition of the "Global Biometric Authentication & ... - Estimation & Forecast, 2015-2020" report to ... authentication and identification systems market is expected to ... 2015 to 2020 and generate over $25 billion ...
(Date:8/12/2015)... , Aug. 12, 2015  Synaptics Inc. (NASDAQ: ... interface solutions, today announced that four of its ... solution, have officially been named FIDO Certified™ by ... of the certification, Synaptics, Natural ID™ fingerprint solutions ... Authentication Framework (UAF) standard and are interoperable among ...
Breaking Biology News(10 mins):Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3Global Biometric Authentication & Identification Market 2015: Focus On Modality, Motility & Application - Estimation & Forecasts to 2020 for the $25 Billion Industry 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 3
... 26 The Peter and Patricia Gruber Foundation International Prize ... with an event to be held at Rockefeller University in ... and Neuroscience Prize recipients will be announced live at the ... Brain, and Society." The discussion will feature a panel ...
... at the way that dolphins, whales and porpoises scythe ... maximum aquatic agility. However, no one had ever analysed ... lift that they generate, the drag that they experience ... from Duke University teamed up with Mark Murray from ...
... investigators in the Vanderbilt Center for Structural Biology have ... structure of the largest membrane-spanning protein to date. , ... pictures" of small proteins, large proteins and particularly ... been reluctant to smile for the camera. , In ...
Cached Biology News:NYC science symposium marks Gruber Prize program 10th anniversary 2Dolphins get a lift from delta wing technology 2Structural biology scores with protein snapshot 2Structural biology scores with protein snapshot 3
Synonym: modified Grace's Insect medium...
Schneider's Drosophila - Insect medium...
... more than doubles the benefits of high ... analysis cycles of the standard binary system ... tandem mode. Difficult separations are dramatically improved ... heartcut configurations, on-line sample preparation is fully ...
... We can introduce random mutations to the ... be then cloned into a vector of choice ... Mutation frequency can be set to a ... Number of clones 106-108. Mutations can be ...
Biology Products: